Documents Search Type - Any -SHP DocumentsPharmacy Documents-Requires Excluded Exception Approval-Requires Prior Approval-Requires Step Therapy-Subject to Quantity LimitsPharmacy and TherapeuticsHBR DocumentsOpen Enrollment DocumentsMember FocusBoard of Trustees Terms - Any -;#Excluded Exception Approval;#;#Prior Approval;#;#Prior Approval;#Step Therapy;#;#Prior Approval;#Subject to Quantity Limits;#AcromegalyActinic KeratosisADHD-Narcolepsy AgentsAlcohol/Opioid DependencyAll HBRsAllergic AsthmaAlpha-1 Antitrypsin DeficiencyAmyotrophic Lateral Sclerosis (ALS)Anabolic SteroidsAnemiaAngiotensin II Receptor AntagonistsAnthelminticAntibioticAnticholinergicAnticonvulsantAnticystine AgentAntiemeticsAntifibrinolytic AgentsAntifungalAntihyperlipidemicsAntimigraineAntineoplasticAntineovascularisation agentsAntiobesityAntiparasiticAsthmaAtypical AntipsychoticsAutoimmuneBisphosphanatesBlood DisordersBlood Product DerivativeBone Disorders - OtherBotulinum ToxinsBPHCalcineurin InhibitorCardiac DisorderCentral Precocious Puberty (CPP)CGRP Receptor AntagonistsChelating AgentChemotherapy ProtectantsCholangiocarcinomaCompounded ProductsCorticosteroidCOVID-19COX-2/NSAIDsCryopyrin Associated Periodic Synd (CAPS)Cushing's SyndromeCystic FibrosisCytomegalovirus (CMV)DiabetesDuchenne muscular dystrophyEczemaElectrolyte DisordersEndocrine and Metabolic AgentEnteral Nutritional TherapyEnzymeEnzyme InhibitorEstrogensFertility Products - Non-SpecialtyFertility Products - SpecialtyFibratesFibrinogen, SystemicGastrointestinal AgentGenitourinary AgentsGI DisordersGlaucomaGoutGrowth Hormone and Related DisordersH3 receptor antagonist/inverse agonistHBR AlertHBR UpdateHeartHeart FailureHematological AgentHematologicsHematopoieticsHemophiliaHepatitisHepatitis CHereditary AngioedemaHereditary orotic aciduriaHerpes LabialisHigh Blood PressureHIVHomocystinuriaHormonal TherapiesIBSIBS/RA/PsoriasisIdiopathic Pulmonary FibrosisIdiopathic Thrombocytopenic Purpura (ITP)Immunosuppressive AgentImplementation UpdateInfluenzaInterferonIron OverloadIsotretinoinsIVIGLambert-Eaton myasthenic syndromeLipid DisordersLipodystrophyLong-Acting Beta Agonists (LABA)Lysosomal Storage DisordersMacular DegenerationMelanocortin 1 receptor (MC1-R) agonistMental HealthMigraine ProductMisc CV AgentsMiscellaneous coagulation modifierMovement DisordersMucolytic AgentMultiple SclerosisMycobacterium avium complex (MAC) lung diseaseNarcolepsyNarcolepsy (Other)Nasal SteroidsNeurogenic orthostatic hypotensionNeuromyelitis optica spectrum disorderNeutropeniaOmega-3 Fatty AcidsOncologyOphthalmic ImmunomodulatorsOpioid AnalgesicsOpioid AnalgesicsOpioid Analgesics - Extended-ReleaseOpioid-Induced ConstipationOral TetracyclinesOral/Intranasal Fentanyl ProductsOsteoarthritisOsteoporosisOxazolidinonesParkinson's DiseaseParoxysmal Nocturnal Hemoglobinuria (PNH)Phenylketonuria (PKU)Phosphodiesterase-4 Enzyme InhibitorPhosphodiesterase-4 Enzyme InhibitorProgestinProstaglandinsProteolytic enzymeProton Pump InhibitorsPseudobulbar affectPsoriasis/RAPsycotherapeutic and Neurological AgentsPulmonary arterial hypertensionPulmonary Arterial HypertensionPulmonary arterial hypertensionRA/OncologyRenal DisorderRetinal DisordersRetinoidsRheumatoid ArthritisRosaceaRSVSedative-HypnoticsSeizure DisordersSelect Medical DevicesShort-Acting Beta Agonists - Oral InhSleep DisordersSNRIsSpinal Muscular AtrophySSRIsSubject to Quantity LimitsSublingual Immunotherapy ProductsSystemic Lupus ErythematosusTardive DyskinesiaTestosterone ProductsTetracyclineThyroid Eye DiseaseTopical Acne ProductsTopical AnestheticsTopical Anesthetics - Lidocaine ContainingTopical AntifungalsTopical CorticosteroidsTopical Skin ProductUrea Cycle DisordersUrinary AntispasmodicsVascular endothelial growth factor (VEGF) antagonistsVascular endothelial growth factor (VEGF) inhibitorsVitromacular Adhesion Pharmacy & Therapeutics Committee Plan Integration 10 Nov 2016 Financial Report (final).pdf 11 Contract and Benefit Implementation Update (final).pdf 12 Comparative Analysis of State Health Plan Benefits (final).pdf 13 Dec 2016 PT Meeting (final).pdf 1A-Nov2015-FinancialReport_01-26-2016.pdf 2015 Scorecard Results (Final).pdf 2015-16 State Fiscal Year End Financial Report (final).pdf 2016 Short Session Legislative Agenda (Final).pdf Back 1 (current) 2 3 4 5 6 7 8 9 … Next
